Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and …

Background So far, a comprehensive systematic review and meta-analysis has not been
done of the prevalence of primary antibiotic resistance in Helicobacter pylori in the Asia …

Objective Although mass eradication of Helicobacter pylori has been proposed as a means
to eliminate gastric cancer, its long-term effects remain unclear. Design Mass eradication of …

Helicobacter pylori infection is one of the most common infectious diseases worldwide.
Although the prevalence of H. pylori is gradually decreasing, approximately half of the …

Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-
day triple therapy for the first-line treatment of Helicobacter pylori infection remains poorly …

Significant progress has been obtained since the III Brazilian Consensus Conference on H.
pylori infection held in 2012, in Bento Gonçalves, Brazil, and justify a fourth meeting to …

Background The first-line eradication rate of standard triple therapy for Helicobacter pylori
infection has declined to< 80%, and alternative therapies with> 90% success rates are …

Helicobacter pylori infection is very common in the Spanish population and represents the
main cause of chronic gastritis, peptic ulcer, and gastric cancer. The last iteration of Spanish …

Background Helicobacter pylori infection is still frequent in the community and all infected
subjects should be offered an eradication therapy. Nowadays physicians have to face the …

Helicobacter pylori approximately infect 50% of Spanish population and causes chronic
gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H. pylori …